| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Heart Institute,* School of Medicine, and the Department of Clinical Medicine, Clinical Immunology, and Allergy, University of São Paulo, São Paulo, Brazil
Heart lesions of rheumatic heart disease (RHD) patients contain T-cell clones that recognize heart proteins and streptococcal M peptides. To functionally characterize heart-infiltrating T lymphocytes, we evaluated their cytokine profile, both directly in situ and in T-cell lines derived from the heart (HIL). Interferon (IFN)-
, tumor necrosis factor (TNF)-
, interleukin (IL)-4, and IL-10 expressions were characterized in 20 heart tissue infiltrates from 14 RHD patients by immunohistochemistry. IFN--, TNF--, and IL-10-positive cells were consistently predominant, whereas IL-4 was scarce in the valves. In agreement with these data, the in vitro experiments, in which 13 HILs derived from heart samples of eight patients were stimulated with M5 protein and the immunodominant M5 (81-96) peptide, IL-4 was detected in HIL derived from the atrium (three of six) but not from the valve (zero of seven). IFN- and IL-10 production were detected in culture supernatants in 11 of 13 and 6 of 12 HILs, respectively. The predominant IFN- and TNF- expression in the heart suggests that Th1-type cytokines could mediate RHD. Unlike in reversible myocardium inflammation, the significantly lower IL-4 expression in the valvular tissue (P = 0.02) may contribute to the progression of the RHD leading to permanent valvular damage (relative risk, 4.3; odds ratio, 15.8). The lack of IL-4 in vitro production by valve-derived HIL also emphasizes the more severe tissue destruction in valves observed in RHD.
This article has been cited by other articles:
 |
|
 |
|
  F. Antonini-Canterin, E. Leiballi, R. Enache, B. A. Popescu, M. Rosca, E. Cervesato, R. Piazza, C. Ginghina, and G. L. Nicolosi Hydroxymethylglutaryl Coenzyme-A Reductase Inhibitors Delay the Progression of Rheumatic Aortic Valve Stenosis: A Long-Term Echocardiographic Study J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1874 - 1879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Ben-Yehuda and A. N. DeMaria Statins in Rheumatic Heart Disease: Taking the Bite Out? J. Am. Coll. Cardiol., May 19, 2009; 53(20): 1880 - 1882. [Full Text] [PDF]
|
|
|
|
|
|
K. Toutouzas, M. Drakopoulou, A. Synetos, E. Tsiamis, G. Agrogiannis, N. Kavantzas, E. Patsouris, D. Iliopoulos, S. Theodoropoulos, M. Yacoub, et al. In Vivo Aortic Valve Thermal Heterogeneity in Patients With Nonrheumatic Aortic Valve Stenosis: The First In Vivo Experience in Humans J. Am. Coll. Cardiol., August 26, 2008; 52(9): 758 - 763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Fann, N. B. Ingels Jr., and D. C. Miller Pathophysiology of Mitral Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 973 - 1012. [Full Text]
|
|
|
|
 |
|
 A. H Chester and P. M Taylor Molecular and functional characteristics of heart-valve interstitial cells Phil Trans R Soc B, August 29, 2007; 362(1484): 1437 - 1443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Fae, D. D. da Silva, S. E. Oshiro, A. C. Tanaka, P. M. A. Pomerantzeff, C. Douay, D. Charron, A. Toubert, M. W. Cunningham, J. Kalil, et al. Mimicry in Recognition of Cardiac Myosin Peptides by Heart-Intralesional T Cell Clones from Rheumatic Heart Disease J. Immunol., May 1, 2006; 176(9): 5662 - 5670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. J. Ellis, Y. Li, W. Hildebrand, V. A. Fischetti, and M. W. Cunningham T Cell Mimicry and Epitope Specificity of Cross-Reactive T Cell Clones from Rheumatic Heart Disease J. Immunol., October 15, 2005; 175(8): 5448 - 5456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Blank, A Aron-Maor, and Y Shoenfeld From rheumatic fever to Libman-Sacks endocarditis: is there any possible pathogenetic link? Lupus, September 1, 2005; 14(9): 697 - 701. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
